Coherus Oncology (CHRS) Stock Insights

CHRS price $1.16 +0.09 +8.41%

Ticker
CHRS
Price
$1.16
Change
+0.09 +8.41%
Market cap ?
$179.22M
P/E ?
-1.05
Forward P/E ?
3.92
Dividend yield ?
0.00%
Beta ?
0.99
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
1901060001556000155600035607100047582400032655100021104200025724400026696000042172000

Coherus Oncology, Inc. is a biopharmaceutical company primarily focused on the research, development, and commercialization of cancer immunotherapies across the United States. The company's commercialized products include several biosimilar therapies. These comprise UDENYCA, a long-acting granulocyte-colony stimulating factor biosimilar to Neulasta; YUSIMRY, an equivalent to Humira, prescribed for inflammatory…

Fair value

CHRS fair value $6.48. Price $1.16. Price is 82% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 13.02M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.73% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 154.50M. Net debt -48.54M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare CHRS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.21—15.98M
2026-08-05-0.19-0.2514.31M14.41M
2026-05-11-0.25-0.2612.31M14.22M
2026-03-09-0.34-0.3612.75M13.91M
2025-11-06-0.33-0.3211.57M14.09M
2025-08-07-0.34-0.3110.25M11.99M
2025-05-12-0.35-0.317.60M60.96M
2025-03-10-0.44-0.1054.14M44.15M
2024-11-06-0.01-0.1670.77M58.98M
2024-08-08-0.14-0.2164.98M61.37M
2024-05-09-0.32-0.0577.06M80.25M
2024-03-13-0.62-0.2191.52M96.40M
2023-11-06-0.41-0.2174.57M81.78M
2023-08-02-0.38-0.5258.72M82.24M
2023-05-08-0.75-0.6132.44M47.44M
2023-03-06-0.60-0.6445.35M47.69M
2022-11-08-0.96-0.5345.42M56.69M
2022-08-04-0.65-0.9660.15M62.04M
2022-05-05-1.24-0.8060.12M69.54M
2022-02-17-0.60-0.6173.37M82.61M
2021-11-08-0.49-0.4082.50M61.88M
2021-08-05-0.40-0.2587.64M88.18M
2021-05-06-2.370.0983.03M99.57M
2021-02-240.120.23110.42M115.12M
2020-11-050.330.41113.55M135.71M
2020-08-060.700.33135.67M100.00M
2020-05-070.540.56116.18M135.54M
2020-02-270.560.72123.86M161.46M
2019-11-060.630.51111.68M90.41M
2019-08-010.32-0.0883.43M—
2019-05-09-0.29-0.4637.10M60.12M
2019-02-28-0.92-0.82——
2018-11-08-0.87-0.79——
2018-08-08-0.68-0.70——
2018-05-10-0.74-0.77——
2018-03-08-0.84-0.81—1.50M
2017-11-06-1.09-1.05—1.16M
2017-08-07-1.08-1.291.40M1.55M
2017-05-08-1.54-1.54161.00K143.23K
2017-03-13-1.71-1.63844.00K542.92K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-05Satvat Ali J.Buy60.00K$1.4587.00K
2026-06-05Satvat Ali J.Buy30.00K——
2026-06-05Karachun Rita ABuy60.00K$1.4587.00K
2026-06-05Karachun Rita ABuy30.00K——
2026-06-05Newcomer Lee NisleyBuy60.00K$1.4587.00K
2026-06-05Newcomer Lee NisleyBuy30.00K——
2026-06-05Ryan Michael LeeBuy60.00K$1.4587.00K
2026-06-05Ryan Michael LeeBuy30.00K——
2026-06-05O'Donnell-Tormey JillBuy60.00K$1.4587.00K
2026-06-05O'Donnell-Tormey JillBuy30.00K——
2026-06-05Wahlstrom MatsBuy60.00K$1.4587.00K
2026-06-05Wahlstrom MatsBuy30.00K——
2026-06-05Newton Charles W.Buy60.00K$1.4587.00K
2026-06-05Newton Charles W.Buy30.00K——
2026-05-29McMichael Bryan JBuy100.00K$1.59159.00K
2026-05-29McMichael Bryan JBuy30.00K$1.5947.70K
2026-05-29McMichael Bryan JBuy25.00K$1.5939.75K
2026-05-29McMichael Bryan JBuy15.00K$1.5923.85K
2026-05-29McMichael Bryan JSell25.00K$6.00150.00K
2026-05-29McMichael Bryan JSell30.00K$5.44163.20K
2026-05-29McMichael Bryan JSell100.00K$14.761.48M
2026-05-29McMichael Bryan JSell25.00K$14.67366.75K
2026-05-29McMichael Bryan JSell15.00K$10.78161.70K
2026-05-29McMichael Bryan JSell25.00K$9.87246.75K
2026-05-29Lanfear Dennis MBuy500.00K$1.59795.00K
2026-05-29Lanfear Dennis MBuy450.00K$1.59715.50K
2026-05-29Lanfear Dennis MBuy402.50K$1.59639.98K
2026-05-29Lanfear Dennis MBuy400.00K$1.59636.00K
2026-05-29Lanfear Dennis MBuy225.00K$1.59357.75K
2026-05-29Lanfear Dennis MBuy200.00K$1.59318.00K
2026-05-29Lanfear Dennis MBuy125.00K$1.59198.75K
2026-05-29Lanfear Dennis MSell402.50K$10.374.17M
2026-05-29Lanfear Dennis MSell225.00K$5.441.22M
2026-05-29Lanfear Dennis MSell500.00K$18.339.16M
2026-05-29Lanfear Dennis MSell500.00K$17.738.87M
2026-05-29Lanfear Dennis MSell450.00K$12.375.57M
2026-05-29Lanfear Dennis MSell400.00K$10.054.02M
2026-05-29Lanfear Dennis MSell125.00K$17.602.20M
2026-05-29Lanfear Dennis MSell200.00K$12.702.54M
2026-05-29Lanfear Dennis MSell402.50K$15.946.42M
2026-01-23Lanfear Dennis MBuy375.00K——
2026-01-23Lanfear Dennis MBuy750.00K$2.061.54M
2026-01-22McMichael Bryan JBuy225.00K$1.59357.75K
2026-01-22McMichael Bryan JBuy112.50K——
2026-01-20McMichael Bryan JSell1.72K$1.552.66K
2026-01-20Lanfear Dennis MSell11.84K$1.5518.35K
2025-06-12O'Donnell-Tormey JillBuy112.00K$0.7988.52K
2025-06-12Newcomer Lee NisleyBuy112.00K$0.7988.52K
2025-06-12Wahlstrom MatsBuy112.00K$0.7988.52K
2025-06-12Ryan Michael LeeBuy112.00K$0.7988.52K
2025-06-12Karachun Rita ABuy112.00K$0.7988.52K
2025-06-12Erbez GeorgiaBuy112.00K$0.7988.52K
2025-06-12Newton Charles W.Buy112.00K$0.7988.52K
2025-06-12Satvat Ali J.Buy112.00K$0.7988.52K
2025-05-23Wahlstrom MatsSell99.99K$0.7473.88K
2025-05-07McMichael Bryan JBuy200.00K$0.95189.24K
2025-05-07Lanfear Dennis MBuy375.00K$0.95354.82K
2025-01-20McMichael Bryan JSell1.71K$1.392.38K
2025-01-20Reider PaulSell4.86K$1.396.75K
2025-01-20Lanfear Dennis MSell11.81K$1.3916.42K
2025-01-10Lanfear Dennis MBuy575.00K$1.47845.25K
2025-01-07McMichael Bryan JSell1.71K$1.572.69K
2025-01-04Lanfear Dennis MSell11.81K$1.6619.60K
2025-01-04Reider PaulSell2.28K$1.663.78K
2025-01-03McMichael Bryan JBuy160.00K$1.66265.60K
2025-01-03Reider PaulBuy160.00K$1.66265.60K
2024-12-13Reider PaulSell2.07K$1.613.34K
2024-08-07McMichael Bryan JBuy75.00K$1.2493.00K
2024-07-22Lanfear Dennis MBuy196.50K$2.41473.56K
2024-07-22Reider PaulBuy40.00K$2.4196.40K
2024-06-04Karachun Rita ABuy168.00K$1.78299.04K
2024-06-04Erbez GeorgiaBuy114.00K$1.78202.92K
2024-06-03Newton Charles W.Buy112.00K$1.76197.12K
2024-06-03Ryan Michael LeeBuy112.00K$1.76197.12K
2024-06-03Wahlstrom MatsBuy112.00K$1.76197.12K
2024-06-03STOLPER MARKBuy112.00K$1.76197.12K
2024-06-03Newcomer Lee NisleyBuy112.00K$1.76197.12K
2024-06-03TZOUMAKAS KIMBERLY JOBuy112.00K$1.76197.12K
2024-06-03O'Donnell-Tormey JillBuy112.00K$1.76197.12K
2024-05-31Karachun Rita AOther0——
2024-02-20Erbez GeorgiaBuy54.00K$2.59139.86K
2024-02-20Erbez GeorgiaOther0——
2024-02-09Wahlstrom MatsBuy99.99K——
2024-02-09Wahlstrom MatsSell99.99K——
2024-02-01Wahlstrom MatsBuy44.99K$1.6775.00K
2024-02-01Wahlstrom MatsBuy15.00K$1.6725.00K
2024-02-01Wahlstrom MatsSell44.99K$1.6775.00K
2024-01-20Lanfear Dennis MSell11.22K$2.4427.37K
2024-01-20Reider PaulSell4.85K$2.4411.84K
2024-01-20McMichael Bryan JSell1.71K$2.444.17K
2024-01-07McMichael Bryan JSell1.71K$2.874.90K
2024-01-05Lanfear Dennis MBuy575.00K$3.141.81M
2024-01-04Lanfear Dennis MSell11.78K$2.9234.40K
2024-01-04Reider PaulSell2.27K$2.926.64K
2024-01-02McMichael Bryan JBuy125.00K$3.14392.50K
2024-01-02Reider PaulBuy160.00K$3.14502.40K
2023-12-31Stilwell McDavidSell18.44K$3.3361.41K
2023-12-13Reider PaulSell2.05K$2.374.86K
2023-11-22Lanfear Dennis MBuy258.94K$1.42366.92K
2023-11-22Lanfear Dennis MSell223.10K$2.02449.77K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 152, holders -10 vs prior quarter. Ownership 46.23%.

HolderSharesChangeChange %Value
TIMOTHY G. YOUNGQUIST 2020 IRREVOCABLE TRUST13.05M759.82K+6.18%18.27M
BLACKROCK, INC.12.00M1.64M+15.81%16.80M
VANGUARD CAPITAL MANAGEMENT LLC5.95M496.73K+9.11%8.33M
GEODE CAPITAL MANAGEMENT, LLC3.69M563.99K+18.07%5.16M
SAMSARA BIOCAPITAL, LLC3.43M00.00%4.80M
KOHLBERG KRAVIS ROBERTS & CO. L.P.3.04M00.00%4.18M
STATE STREET CORP2.38M56.45K+2.43%3.34M
TWO SIGMA INVESTMENTS, LP2.26M-42.59K-1.85%3.16M
CM MANAGEMENT, LLC2.10M00.00%2.94M
C WORLDWIDE GROUP HOLDING A/S1.93M00.00%2.70M
ALYESKA INVESTMENT GROUP, L.P.1.73M-516.77K-22.97%2.43M
HUDSON BAY CAPITAL MANAGEMENT LP1.69M-11.98K-0.70%2.37M
AQR CAPITAL MANAGEMENT LLC1.33M124.16K+10.29%1.86M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.23M1.23MNew1.72M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.23M72.17K+6.24%1.72M
PANAGORA ASSET MANAGEMENT INC1.14M-321.99K-22.06%1.59M
NORTHERN TRUST CORP1.13M215.67K+23.60%1.58M
VANGUARD FIDUCIARY TRUST CO1.02M66.07K+6.96%1.42M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.900.00K00.00%1.26M
VANGUARD PORTFOLIO MANAGEMENT LLC883.45K278.93K+46.14%1.24M
UBS GROUP AG760.36K213.15K+38.95%1.06M
GOLDMAN SACHS GROUP INC602.08K-94.08K-13.51%842.90K
RENAISSANCE TECHNOLOGIES LLC563.06K231.36K+69.75%788.28K
STRS OHIO395.60K71.60K+22.10%553.84K
BRIDGEWAY CAPITAL MANAGEMENT, LLC391.00K-50.00K-11.34%547.40K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Coherus Oncology (CHRS) Stock Insights

CHRS$1.16+0.09 +8.41%

$179.22M

Market Cap

-1.05

P/E

3.92

Forward P/E

—

Score

Price History